Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 202975, 13 pages
http://dx.doi.org/10.1155/2015/202975
Research Article

Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury

1Department of Surgery, Erasmus MC-University Medical Center, 3015 CE Rotterdam, Netherlands
2Department of Surgery, Penn Transplant Institute, University of Pennsylvania, Philadelphia, PA 19104, USA
3Department of Transplant Immunology, Pathology and Laboratory Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA

Received 9 April 2015; Accepted 27 May 2015

Academic Editor: Bjarne K. Møller

Copyright © 2015 Suomi M. G. Fouraschen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Fausto, “Liver regeneration: from laboratory to clinic,” Liver Transplantation, vol. 7, no. 10, pp. 835–844, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. Shiffman, R. S. Brown Jr., K. M. Olthoff et al., “Living donor liver transplantation: summary of a conference at The National Institutes of Health,” Liver Transplantation, vol. 8, no. 2, pp. 174–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Schindl, D. N. Redhead, K. C. H. Fearon, O. J. Garden, and S. J. Wigmore, “The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection,” Gut, vol. 54, no. 2, pp. 289–296, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Marsh, E. Gray, R. Ness, and T. E. Starzl, “Complications of right lobe living donor liver transplantation,” Journal of Hepatology, vol. 51, no. 4, pp. 715–724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Dahm, P. Georgiev, and P.-A. Clavien, “Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications,” American Journal of Transplantation, vol. 5, no. 11, pp. 2605–2610, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Ben-Haim, S. Emre, T. M. Fishbein et al., “Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease,” Liver Transplantation, vol. 7, no. 11, pp. 948–953, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Wu, P. Wang, J. Rao et al., “Triptolide alleviates hepatic ischemia/reperfusion injury by attenuating oxidative stress and inhibiting NF-κB activity in mice,” The Journal of Surgical Research, vol. 166, no. 2, pp. e205–e213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Selzner, H. Rudiger, R. Graf, and P.-A. Clavien, “Protective strategies against ischemic injury of the liver,” Gastroenterology, vol. 125, no. 3, pp. 917–936, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K.-A. Cho, S.-Y. Ju, S. J. Cho et al., “Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow,” Cell Biology International, vol. 33, no. 7, pp. 772–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. T. Abdel Aziz, H. M. Atta, S. Mahfouz et al., “Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis,” Clinical Biochemistry, vol. 40, no. 12, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Forbes, P. Vig, R. Poulsom, M. R. Alison, and N. A. Wright, “Bone marrow-derived liver stem cells: their therapeutic potential,” Gastroenterology, vol. 123, no. 2, pp. 654–655, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Oertel and D. A. Shafritz, “Stem cells, cell transplantation and liver repopulation,” Biochimica et Biophysica Acta, vol. 1782, no. 2, pp. 61–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Pan, S. M. G. Fouraschen, F. S. F. A. Kaya et al., “Mobilization of hepatic mesenchymal stem cells from human liver grafts,” Liver Transplantation, vol. 17, no. 5, pp. 596–609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Bieback, S. Kern, A. Kocaömer, K. Ferlik, and P. Bugert, “Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood,” Bio-Medical Materials and Engineering, vol. 18, no. 1, pp. S71–S76, 2008. View at Google Scholar · View at Scopus
  16. M. J. Hoogduijn, M. M. A. Verstegen, A. U. Engela et al., “No evidence for circulating mesenchymal stem cells in patients with organ injury,” Stem Cells and Development, vol. 23, no. 19, pp. 2328–2335, 2014. View at Publisher · View at Google Scholar
  17. E. L. de Mare-Bredemeijer, S. Mancham, M. M. Verstegen et al., “Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses,” Stem Cells and Development, vol. 24, no. 12, pp. 1436–1447, 2015. View at Publisher · View at Google Scholar
  18. S. M. G. Fouraschen, Q. Pan, P. E. de Ruiter et al., “Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy,” Stem Cells and Development, vol. 21, no. 13, pp. 2410–2419, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Fouraschen, S. R. R. Hall, J. de Jonge, and L. J. W. van der Laan, “Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cells,” in Animal Models for Stem Cell Therapy, vol. 1213 of Methods in Molecular Biology, pp. 89–104, Springer, New York, NY, USA, 2014. View at Publisher · View at Google Scholar
  20. B. Parekkadan, D. van Poll, K. Suganuma et al., “Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure,” PLoS ONE, vol. 2, no. 9, article e941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. van Poll, B. Parekkadan, C. H. Cho et al., “Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo,” Hepatology, vol. 47, no. 5, pp. 1634–1643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Pan, S. M. Fouraschen, P. E. de Ruiter et al., “Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells,” Experimental Biology and Medicine, vol. 239, no. 1, pp. 105–115, 2014. View at Publisher · View at Google Scholar
  23. M. Wilm, A. Shevchenko, T. Houthaeve et al., “Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry,” Nature, vol. 379, no. 6564, pp. 466–469, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Ortiz, M. DuTreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Yang, M. Park, I. Yoon et al., “Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10,” Experimental and Molecular Medicine, vol. 41, no. 5, pp. 315–324, 2009. View at Publisher · View at Google Scholar
  26. I. N. Hines, J. M. Hoffman, H. Scheerens et al., “Regulation of postischemic liver injury following different durations of ischemia,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 284, no. 3, pp. G536–G545, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Urakami, Y. Abe, and M. B. Grisham, “Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 9, pp. 912–919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Abu-Amara, S. Y. Yang, N. Tapuria, B. Fuller, B. Davidson, and A. Seifalian, “Liver ischemia/reperfusion injury: processes in inflammatory networks—a review,” Liver Transplantation, vol. 16, no. 9, pp. 1016–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Llacuna, M. Marí, J. M. Lluis, C. García-Ruiz, J. C. Fernández-Checa, and A. Morales, “Reactive oxygen species mediate liver injury through parenchymal nuclear factor-κB inactivation in prolonged ischemia/reperfusion,” The American Journal of Pathology, vol. 174, no. 5, pp. 1776–1785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Hanschen, S. Zahler, F. Krombach, and A. Khandoga, “Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion,” Transplantation, vol. 86, no. 5, pp. 710–718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. C. Lai, F. Arslan, M. M. Lee et al., “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury,” Stem Cell Research, vol. 4, no. 3, pp. 214–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Souidi, M. Stolk, and M. Seifert, “Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells,” Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 34–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-T. Chen, C.-K. Sun, Y.-C. Lin et al., “Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction,” Journal of Translational Medicine, vol. 9, article 51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H.-K. Yip, Y.-C. Chang, C. G. Wallace et al., “Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury,” Journal of Pineal Research, vol. 54, no. 2, pp. 207–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. D. van Poll, B. Parekkadan, C. H. Cho et al., “Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo,” Hepatology, vol. 47, no. 5, pp. 1634–1643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. W. Duncan, C. Dorrell, and M. Grompe, “Stem cells and liver regeneration,” Gastroenterology, vol. 137, no. 2, pp. 466–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Fausto, “Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells,” Hepatology, vol. 39, no. 6, pp. 1477–1487, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Kaplan, M. E. Youd, and T. A. Lodie, “Immunomodulatory activity of mesenchymal stem cells,” Current Stem Cell Research & Therapy, vol. 6, no. 4, pp. 297–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Crop, C. Baan, W. Weimar, and M. Hoogduijn, “Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation,” Transplant International, vol. 22, no. 4, pp. 365–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Abarbanell, Y. Wang, J. L. Herrmann et al., “Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 5, pp. H1529–H1536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Du, C. Wei, K. Cheng et al., “Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation,” Journal of Surgical Research, vol. 183, no. 2, pp. 907–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Ma, H. Liu, W. Chen et al., “Implanted adipose-derived stem cells attenuate small-for-size liver graft injury by secretion of VEGF in rats,” The American Journal of Transplantation, vol. 12, no. 3, pp. 620–629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi et al., “Human adipose–derived mesenchymal stem cells attenuate liver ischemia–reperfusion injury and promote liver regeneration,” Surgery, vol. 156, no. 5, pp. 1225–1231, 2014. View at Publisher · View at Google Scholar
  44. H. Kanazawa, Y. Fujimoto, T. Teratani et al., “Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model,” PLoS ONE, vol. 6, no. 4, Article ID e19195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Wang, Z. Du, J. Yan et al., “Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB,” PLoS ONE, vol. 9, no. 12, Article ID e112532, 2014. View at Publisher · View at Google Scholar
  46. G. Jin, G. Qiu, D. Wu et al., “Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats,” International Journal of Molecular Medicine, vol. 31, no. 6, pp. 1395–1401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. G.-Z. Pan, Y. Yang, J. Zhang et al., “Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats,” Journal of Surgical Research, vol. 178, no. 2, pp. 935–948, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Fu, H. Zhang, Y. Zhuang et al., “The role of N-acetyltransferase 8 in mesenchymal stem cell-based therapy for liver ischemia/reperfusion injury in rats,” PLoS ONE, vol. 9, no. 7, Article ID e103355, 2014. View at Publisher · View at Google Scholar
  49. S. C. Lee, J. O. Kim, and S. Kim, “Secretome from human adipose-derived stem cells protects mouse liver from hepatic ischemia–reperfusion injury,” Surgery, vol. 157, no. 5, pp. 934–943, 2015. View at Publisher · View at Google Scholar
  50. T. Seki, Y. Yokoyama, H. Nagasaki, T. Kokuryo, and M. Nagino, “Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats,” Journal of Surgical Research, vol. 178, no. 1, pp. 63–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Hu, K. Srivastava, M. Wieland et al., “Endothelial cell-derived Angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat,” Science, vol. 343, no. 6169, pp. 416–419, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Eggenhofer, V. Benseler, A. Kroemer et al., “Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion,” Frontiers in Immunology, vol. 3, article 97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. H. Dahlke, M. Hoogduijn, E. Eggenhofer et al., “Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group,” Transplantation, vol. 88, no. 5, pp. 614–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Chen, S. Zhang, J.-C. Wen et al., “Several types of soft tissue sarcomas originate from the malignant transformation of adipose tissue-derived stem cells,” Molecular Medicine Reports, vol. 3, no. 3, pp. 441–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Steinemann, G. Gohring, and B. Schlegelberger, “Genetic instability of modified stem cells—a first step towards malignant transformation?” American Journal of Stem Cells, vol. 2, no. 1, pp. 39–51, 2013. View at Google Scholar
  56. M. B. H. Sanchez, S. Bruno, C. Grange et al., “Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury,” Stem Cell Research & Therapy, vol. 5, no. 6, article 124, 2014. View at Publisher · View at Google Scholar
  57. S. K. Lee, S. C. Lee, and S. Kim, “A novel cell-free strategy for promoting mouse liver regeneration: utilization of a conditioned medium from adipose-derived stem cells,” Hepatology International, vol. 9, no. 2, pp. 310–320, 2015. View at Publisher · View at Google Scholar